These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21079627)

  • 21. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for financial sustainability of immunization programs: a review of the strategies from 50 national immunization program financial sustainability plans.
    Kamara L; Milstien JB; Patyna M; Lydon P; Levin A; Brenzel L
    Vaccine; 2008 Dec; 26(51):6717-26. PubMed ID: 18955100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GAVI funding meeting exceeds expectations.
    Usher AD
    Lancet; 2011 Jun; 377(9784):2165-6. PubMed ID: 21714163
    [No Abstract]   [Full Text] [Related]  

  • 24. A new approach to global health institutions? A case study of new vaccine introduction and the formation of the GAVI Alliance.
    Sandberg KI; Andresen S; Bjune G
    Soc Sci Med; 2010 Oct; 71(7):1349-1356. PubMed ID: 20692756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GAVI gears up for record replenishment.
    Usher AD
    Lancet; 2014 Jul; 384(9939):219-20. PubMed ID: 25050437
    [No Abstract]   [Full Text] [Related]  

  • 26. GAVI takes steps to address funding woes.
    Usher AD
    Lancet; 2011 Feb; 377(9764):453. PubMed ID: 21300591
    [No Abstract]   [Full Text] [Related]  

  • 27. Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries.
    Saxenian H; Hecht R; Kaddar M; Schmitt S; Ryckman T; Cornejo S
    Health Policy Plan; 2015 Mar; 30(2):197-205. PubMed ID: 24510369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A global health partnership's use of time-limited support to catalyze health practice change: the case of GAVI's Injection Safety Support.
    Levin A; Fang A; Hansen PM; Pyle D; Dia O; Schwalbe N
    PLoS One; 2010 Sep; 5(9):e12986. PubMed ID: 20885995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Global Alliance for Vaccines and Immunization (GAVI) in Accelerating Inactivated Polio Vaccine Introduction.
    Thacker N; Thacker D; Pathak A
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S57-S60. PubMed ID: 27771641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viewpoint: immunization against poverty.
    Godal T
    Trop Med Int Health; 2000 Mar; 5(3):160-6. PubMed ID: 10747277
    [No Abstract]   [Full Text] [Related]  

  • 31. Global alliance for vaccines and immunization (GAVI).
    Indian J Med Sci; 2001 Nov; 55(11):635-9. PubMed ID: 12508637
    [No Abstract]   [Full Text] [Related]  

  • 32. Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries. A WHO/ICO HPV Information Centre Report.
    de Sanjosé S; Serrano B; Castellsagué X; Brotons M; Muñoz J; Bruni L; Bosch FX
    Vaccine; 2012 Nov; 30 Suppl 4():D1-83, vi. PubMed ID: 23510764
    [No Abstract]   [Full Text] [Related]  

  • 33. GAVI, the Vaccine Alliance.
    Zerhouni E
    Cell; 2019 Sep; 179(1):13-17. PubMed ID: 31519310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunizations and vaccines: a decade of successes and reversals, and a call for 'vaccine diplomacy'.
    Hotez PJ
    Int Health; 2019 Sep; 11(5):331-333. PubMed ID: 31034023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The contribution of immunization: saving millions of lives, and more.
    Chan M
    Public Health Rep; 2014; 129 Suppl 3(Suppl 3):7-8. PubMed ID: 25100885
    [No Abstract]   [Full Text] [Related]  

  • 36. Innovative financing instruments for global health 2002-15: a systematic analysis.
    Atun R; Silva S; Knaul FM
    Lancet Glob Health; 2017 Jul; 5(7):e720-e726. PubMed ID: 28619230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Status of New Vaccine Introduction - Worldwide, September 2016.
    Loharikar A; Dumolard L; Chu S; Hyde T; Goodman T; Mantel C
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1136-1140. PubMed ID: 27764083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccines and future global health needs.
    Nossal GJ
    Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2833-40. PubMed ID: 21893548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs.
    Chauke-Moagi BE; Mumba M
    Vaccine; 2012 Sep; 30 Suppl 3():C3-8. PubMed ID: 22939018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GAVI, the first steps: lessons for the Global Fund.
    Brugha R; Starling M; Walt G
    Lancet; 2002 Feb; 359(9304):435-8. PubMed ID: 11844535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.